High Mark Wealth Management LLC X4 Pharmaceuticals, Inc Transaction History
High Mark Wealth Management LLC
- $182 Million
- Q3 2024
A detailed history of High Mark Wealth Management LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, High Mark Wealth Management LLC holds 180 shares of XFOR stock, worth $100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180
Previous 180
-0.0%
Holding current value
$100
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding XFOR
# of Institutions
103Shares Held
99.9MCall Options Held
213KPut Options Held
50.6K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$9.47 Million2.03% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$8.39 Million0.77% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$5.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.44MShares$4.73 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$3.99 Million0.11% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $38.4M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...